ACLIDINIUM BROMIDE

ACLIDINIUM BROMIDE was reported 5575 times

ACLIDINIUM BROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD PRESSURE AMBULATORY ABNORMAL 7 0.4667
1 HYPER IGE SYNDROME 43 0.4526
2 OCCUPATIONAL ASTHMA 20 0.4000
3 CONGENITAL HIATUS HERNIA 25 0.3846
4 TOTAL LUNG CAPACITY INCREASED 55 0.3481
5 DYSPONESIS 3 0.2308
6 FUNGAL DISEASE CARRIER 14 0.2090
7 AIRWAY REMODELLING 16 0.1905
8 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 58 0.1859
9 URINARY TRACT DISCOMFORT 51 0.1700
10 NEUROSENSORY HYPOACUSIS 14 0.1474
11 LUNG DIFFUSION DISORDER 14 0.1414
12 ALVEOLAR OSTEITIS 50 0.1397
13 MYCOBACTERIUM TEST POSITIVE 19 0.1195
14 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 52 0.0904
15 BILEVEL POSITIVE AIRWAY PRESSURE 8 0.0879
16 INTENTIONAL DEVICE MISUSE 336 0.0826
17 LUNG DIFFUSION TEST DECREASED 19 0.0809
18 NSAID EXACERBATED RESPIRATORY DISEASE 4 0.0667
19 ANIMAL SCRATCH 49 0.0644
20 VITAL CAPACITY DECREASED 23 0.0625
21 OESOPHAGEAL DILATATION 20 0.0568
22 MEDIASTINAL SHIFT 3 0.0556
23 RESTRICTIVE PULMONARY DISEASE 51 0.0555
24 NASAL POLYPS 117 0.0537
25 PRESBYACUSIS 14 0.0502
26 FEMALE STERILISATION 19 0.0463
27 SINUS PAIN 73 0.0452
28 INGUINAL HERNIA REPAIR 13 0.0433
29 BREAST CONSERVING SURGERY 15 0.0425
30 BRONCHIECTASIS 193 0.0403
31 POSITIVE AIRWAY PRESSURE THERAPY 3 0.0385
32 PANCREATIC CALCIFICATION 4 0.0360
33 CARCINOMA IN SITU 5 0.0352
34 OBSTRUCTIVE AIRWAYS DISORDER 313 0.0350
35 TUNNEL VISION 51 0.0347
36 POLYCYSTIC OVARIES 45 0.0319
37 PNEUMOTHORAX SPONTANEOUS 16 0.0307
38 POLYMYALGIA RHEUMATICA 65 0.0301
39 ANTI-THYROID ANTIBODY 2 0.0294
40 RESPIRATORY TRACT OEDEMA 16 0.0294
41 BLOOD IMMUNOGLOBULIN E DECREASED 3 0.0291
42 CAROTID ARTERIOSCLEROSIS 21 0.0275
43 LIPOHYPERTROPHY 14 0.0275
44 DEVICE MALFUNCTION 1275 0.0274
45 DEVICE FAILURE 296 0.0260
46 ATOPY 5 0.0259
47 BRONCHIAL WALL THICKENING 14 0.0246
48 EAR CONGESTION 51 0.0241
49 BREATH SOUNDS ABNORMAL 88 0.0239
50 STRESS URINARY INCONTINENCE 22 0.0236
51 INSPIRATORY CAPACITY DECREASED 3 0.0229
52 BLADDER PAIN 57 0.0228
53 MALIGNANT MELANOMA IN SITU 25 0.0225
54 BRONCHITIS CHRONIC 43 0.0203
55 OROPHARYNGEAL CANDIDIASIS 14 0.0197
56 PARANASAL SINUS DISCOMFORT 52 0.0196
57 MITRAL VALVE REPAIR 5 0.0186
58 WOUND COMPLICATION 51 0.0184
59 LAPAROSCOPIC SURGERY 3 0.0182
60 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 124 0.0177
61 EOSINOPHILIC BRONCHITIS 3 0.0175
62 RHINITIS ALLERGIC 57 0.0169
63 BRONCHIAL OBSTRUCTION 20 0.0167
64 VOCAL CORD INFLAMMATION 4 0.0167
65 FULL BLOOD COUNT ABNORMAL 107 0.0166
66 OBSTRUCTIVE PANCREATITIS 6 0.0164
67 BREAST NEOPLASM 14 0.0162
68 SPUTUM PURULENT 9 0.0160
69 CHRONIC SINUSITIS 44 0.0159
70 LUNG OPACITY 20 0.0158
71 GRANULOMATOSIS WITH POLYANGIITIS 13 0.0157
72 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 7 0.0155
73 BODY HEIGHT DECREASED 148 0.0152
74 TOTAL LUNG CAPACITY DECREASED 18 0.0151
75 WOUND SECRETION 51 0.0151
76 ORTHOSTATIC INTOLERANCE 9 0.0151
77 SPUTUM DISCOLOURED 110 0.0151
78 ALLERGY TO ANIMAL 10 0.0150
79 STENOTROPHOMONAS INFECTION 14 0.0148
80 SARCOIDOSIS 55 0.0147
81 NEPHRECTOMY 17 0.0146
82 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 605 0.0143
83 MACROCYTOSIS 14 0.0143
84 JAUNDICE CHOLESTATIC 42 0.0142
85 MUSCLE STRENGTH ABNORMAL 3 0.0141
86 MYOPATHY 97 0.0139
87 KYPHOSIS 21 0.0138
88 CALCULUS URINARY 17 0.0135
89 PERSONAL RELATIONSHIP ISSUE 8 0.0135
90 LORDOSIS 4 0.0134
91 HYPOMANIA 41 0.0132
92 SINUSITIS BACTERIAL 9 0.0131
93 HYPERCAPNIA 30 0.0127
94 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 11 0.0125
95 DEVICE DEFECTIVE 66 0.0122
96 CREPITATIONS 32 0.0121
97 RALES 57 0.0119
98 NOCTURNAL DYSPNOEA 12 0.0119
99 EMPHYSEMA 101 0.0119
100 DYSLIPIDAEMIA 47 0.0118
101 BODY HEIGHT INCREASED 3 0.0118
102 ANGIOPLASTY 15 0.0115
103 BLOOD IRON DECREASED 96 0.0113
104 SALIVA DISCOLOURATION 3 0.0110
105 INTENTIONAL PRODUCT MISUSE 740 0.0108
106 FORCED EXPIRATORY VOLUME DECREASED 23 0.0107
107 PULMONARY FUNCTION TEST DECREASED 39 0.0106
108 PAINFUL RESPIRATION 21 0.0100
109 WHEEZING 432 0.0100
110 INTENTIONAL DEVICE USE ISSUE 4 0.0100
111 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 5 0.0097
112 REVERSIBLE AIRWAYS OBSTRUCTION 4 0.0092
113 VITAMIN D INCREASED 4 0.0089
114 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 185 0.0089
115 LUNG CONSOLIDATION 20 0.0088
116 PULMONARY FUNCTION TEST ABNORMAL 11 0.0088
117 MITE ALLERGY 3 0.0087
118 GLOSSITIS 24 0.0082
119 LUNG HYPERINFLATION 6 0.0082
120 DEVICE ISSUE 475 0.0080
121 NASAL DISCHARGE DISCOLOURATION 8 0.0079
122 ASTHMA 611 0.0078
123 AMNESTIC DISORDER 3 0.0078
124 PRODUCT TASTE ABNORMAL 82 0.0078
125 ASTHMA EXERCISE INDUCED 2 0.0077
126 PRODUCTIVE COUGH 265 0.0076
127 OXYGEN CONSUMPTION DECREASED 4 0.0076
128 BRONCHIOLITIS 21 0.0075
129 PULMONARY PAIN 15 0.0075
130 FRUSTRATION TOLERANCE DECREASED 44 0.0075
131 CARDIAC MURMUR 56 0.0074
132 INCORRECT DOSE ADMINISTERED BY PRODUCT 6 0.0073
133 GRANULOMA 20 0.0072
134 AORTIC ARTERIOSCLEROSIS 15 0.0072
135 SKIN LACERATION 53 0.0070
136 MESOTHELIOMA 3 0.0070
137 SINUS DISORDER 110 0.0070
138 ADENOCARCINOMA 13 0.0070
139 LUNG NEOPLASM 26 0.0068
140 OBSTRUCTION 19 0.0068
141 CREATININE RENAL CLEARANCE INCREASED 4 0.0067
142 CUSHINGOID 16 0.0066
143 BLOOD IMMUNOGLOBULIN E INCREASED 12 0.0064
144 HYPERCHOLESTEROLAEMIA 41 0.0063
145 BENIGN PROSTATIC HYPERPLASIA 27 0.0062
146 DRUG DOSE OMISSION 1017 0.0061
147 BODY MASS INDEX INCREASED 6 0.0061
148 UPPER-AIRWAY COUGH SYNDROME 36 0.0059
149 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 186 0.0059
150 DIZZINESS EXERTIONAL 3 0.0059
151 BLOOD TEST ABNORMAL 61 0.0058
152 BODY TEMPERATURE INCREASED 99 0.0058
153 PULMONARY MASS 65 0.0057
154 LOWER RESPIRATORY TRACT INFECTION 181 0.0056
155 ANION GAP INCREASED 6 0.0055
156 EOSINOPHIL COUNT INCREASED 35 0.0055
157 RESPIRATORY SYMPTOM 9 0.0055
158 DYSPNOEA EXERTIONAL 153 0.0054
159 BLOOD CHOLESTEROL 2 0.0054
160 BRONCHITIS BACTERIAL 3 0.0053
161 OXYGEN THERAPY 5 0.0053
162 SLEEP APNOEA SYNDROME 85 0.0053
163 HALO VISION 5 0.0052
164 THROAT LESION 3 0.0051
165 JOINT INJURY 85 0.0050
166 RESPIRATORY TRACT IRRITATION 4 0.0050
167 PRODUCT QUALITY ISSUE 592 0.0049
168 SMALL CELL LUNG CANCER 5 0.0049
169 ACCIDENT AT HOME 2 0.0049
170 PRODUCT OUTER PACKAGING ISSUE 3 0.0049
171 NEUROPSYCHIATRIC SYMPTOMS 5 0.0049
172 ORAL CANDIDIASIS 47 0.0048
173 SPUTUM INCREASED 7 0.0047
174 PULMONARY CONGESTION 48 0.0046
175 SCHIZOPHRENIA 42 0.0046
176 REFLUX GASTRITIS 4 0.0045
177 VENTRICULAR HYPOKINESIA 12 0.0045
178 HYPOKINESIA 54 0.0045
179 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 208 0.0045
180 PAROTITIS 4 0.0044
181 HYPOAESTHESIA ORAL 53 0.0043
182 SENSITIVITY TO WEATHER CHANGE 16 0.0043
183 LUNG DISORDER 161 0.0043
184 LIMB DEFORMITY 6 0.0043
185 OSTEOPOROTIC FRACTURE 6 0.0042
186 GLAUCOMA 65 0.0042
187 BLOOD CHOLESTEROL ABNORMAL 15 0.0041
188 BLOOD PRESSURE SYSTOLIC INCREASED 63 0.0041
189 TONGUE INJURY 3 0.0040
190 BLOOD COUNT ABNORMAL 62 0.0040
191 INFUSION SITE BRUISING 5 0.0040
192 MACULAR DEGENERATION 36 0.0039
193 LIMB INJURY 79 0.0038
194 BLOOD URINE PRESENT 61 0.0038
195 PNEUMONIA INFLUENZAL 3 0.0038
196 DEVICE USE ISSUE 37 0.0038
197 DRUG DELIVERY SYSTEM ISSUE 4 0.0038
198 MULTIPLE ALLERGIES 22 0.0038
199 RENAL CYST 25 0.0037
200 DEVICE DAMAGE 3 0.0037
201 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 100 0.0037
202 PERICARDIAL HAEMORRHAGE 7 0.0037
203 VOCAL CORD DISORDER 6 0.0037
204 PERIPHERAL VASCULAR DISORDER 17 0.0037
205 PSEUDOMONAS INFECTION 23 0.0036
206 EAR PAIN 56 0.0036
207 GASTROENTERITIS 42 0.0036
208 OXYGEN SATURATION ABNORMAL 7 0.0036
209 CORONARY ARTERY DISEASE 100 0.0036
210 ABSCESS 45 0.0036
211 DYSPNOEA 1615 0.0036
212 INSURANCE ISSUE 20 0.0036
213 HYPOACUSIS 113 0.0036
214 SUFFOCATION FEELING 7 0.0035
215 URINE FLOW DECREASED 7 0.0035
216 FANCONI SYNDROME 4 0.0035
217 RESTLESS LEGS SYNDROME 52 0.0035
218 SECRETION DISCHARGE 30 0.0034
219 CHRONIC RESPIRATORY FAILURE 3 0.0034
220 GASTROOESOPHAGEAL REFLUX DISEASE 213 0.0034
221 BRONCHITIS 207 0.0033
222 TYPE 2 DIABETES MELLITUS 89 0.0033
223 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I 3 0.0033
224 SYMPTOM RECURRENCE 9 0.0033
225 RESPIRATION ABNORMAL 16 0.0032
226 DYSPHONIA 147 0.0032
227 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 2 0.0032
228 PRODUCT DOSE OMISSION 210 0.0032
229 LUNG NEOPLASM MALIGNANT 109 0.0030
230 APHONIA 32 0.0030
231 MICTURITION URGENCY 27 0.0030
232 BRONCHIAL DISORDER 4 0.0030
233 SKIN LESION 63 0.0030
234 CHOKING 45 0.0030
235 CONJUNCTIVITIS ALLERGIC 3 0.0030
236 CATARACT 130 0.0029
237 DISABILITY 45 0.0029
238 TUMOUR PAIN 3 0.0029
239 PROSTATITIS 7 0.0028
240 CANDIDA INFECTION 34 0.0028
241 SUBCUTANEOUS HAEMATOMA 3 0.0027
242 RIB FRACTURE 44 0.0027
243 PYELONEPHRITIS 18 0.0027
244 NOSOCOMIAL INFECTION 5 0.0026
245 OROPHARYNGEAL DISCOMFORT 15 0.0026
246 NASAL SEPTUM DEVIATION 4 0.0026
247 OVERWEIGHT 11 0.0026
248 COUGH 551 0.0026
249 OESOPHAGEAL SPASM 4 0.0026
250 DYSURIA 78 0.0026
251 LUMBAR VERTEBRAL FRACTURE 9 0.0026
252 VISUAL ACUITY REDUCED 78 0.0025
253 ECZEMA 58 0.0025
254 HYPOTHYROIDISM 60 0.0025
255 PROCEDURAL PAIN 52 0.0025
256 WRIST FRACTURE 24 0.0025
257 NEUROLOGICAL SYMPTOM 11 0.0025
258 DERMATITIS ATOPIC 34 0.0025
259 HEPATOTOXICITY 41 0.0024
260 RHINITIS 15 0.0024
261 MIDDLE INSOMNIA 34 0.0024
262 CHEST DISCOMFORT 189 0.0024
263 EOSINOPHILIA 32 0.0024
264 INCREASED BRONCHIAL SECRETION 4 0.0024
265 RESPIRATORY TRACT CONGESTION 29 0.0024
266 CELLULITIS 98 0.0024
267 DRY THROAT 19 0.0023
268 BLOOD PRESSURE ABNORMAL 34 0.0023
269 TYMPANIC MEMBRANE PERFORATION 3 0.0023
270 PANIC ATTACK 68 0.0023
271 GASTRITIS HAEMORRHAGIC 3 0.0023
272 FEELING COLD 52 0.0023
273 ESCHERICHIA INFECTION 14 0.0023
274 PNEUMONIA 568 0.0023
275 NASAL OEDEMA 3 0.0023
276 TONGUE DISCOMFORT 7 0.0023
277 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0022
278 ARTERIAL HAEMORRHAGE 2 0.0022
279 HEART RATE INCREASED 174 0.0022
280 ABDOMINAL TENDERNESS 9 0.0022
281 CORONARY ARTERY BYPASS 11 0.0022
282 PANIC DISORDER 7 0.0021
283 MYCOBACTERIAL INFECTION 3 0.0021
284 READING DISORDER 4 0.0021
285 MOVEMENT DISORDER 56 0.0021
286 PNEUMONIA VIRAL 5 0.0021
287 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0021
288 MITRAL VALVE PROLAPSE 3 0.0021
289 NASAL CONGESTION 90 0.0021
290 RESPIRATORY DISORDER 49 0.0020
291 INCORRECT DOSE ADMINISTERED BY DEVICE 27 0.0020
292 POLLAKIURIA 68 0.0020
293 TRANSIENT ISCHAEMIC ATTACK 58 0.0020
294 HAEMATURIA 59 0.0020
295 ORGANISING PNEUMONIA 7 0.0020
296 VOCAL CORD PARALYSIS 3 0.0020
297 UNDERWEIGHT 3 0.0020
298 ANIMAL BITE 4 0.0020
299 FANCONI SYNDROME ACQUIRED 3 0.0020
300 OSTEOPOROSIS 67 0.0020
301 BLOOD BILIRUBIN INCREASED 44 0.0019
302 INTERVERTEBRAL DISC DISORDER 7 0.0019
303 POLYP 10 0.0019
304 CHEST INJURY 3 0.0019
305 SINUSITIS 153 0.0019
306 EYE DISORDER 48 0.0019
307 RESPIRATORY TRACT INFECTION 35 0.0018
308 NEPHROLITHIASIS 63 0.0018
309 IDIOPATHIC PULMONARY FIBROSIS 5 0.0018
310 VISUAL IMPAIRMENT 166 0.0018
311 OXYGEN SATURATION DECREASED 73 0.0018
312 CHOLELITHIASIS 47 0.0017
313 DYSARTHRIA 54 0.0017
314 PERIPHERAL VENOUS DISEASE 3 0.0017
315 URINARY RETENTION 46 0.0017
316 MEMORY IMPAIRMENT 193 0.0017
317 WEIGHT GAIN POOR 3 0.0017
318 PSYCHOTIC DISORDER 42 0.0017
319 HYPERPARATHYROIDISM SECONDARY 4 0.0017
320 DRUG DELIVERY SYSTEM MALFUNCTION 6 0.0017
321 ENDOMETRIAL CANCER 3 0.0017
322 LARYNGITIS 14 0.0017
323 OXYGEN CONSUMPTION INCREASED 3 0.0017
324 PANIC REACTION 10 0.0017
325 OROPHARYNGEAL PAIN 121 0.0017
326 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0016
327 CARDIAC FAILURE 105 0.0016
328 HERNIA 24 0.0016
329 PRODUCT LABEL ISSUE 8 0.0016
330 DEVICE DELIVERY SYSTEM ISSUE 13 0.0016
331 EAR DISORDER 6 0.0016
332 CATHETER SITE PAIN 3 0.0016
333 BRONCHOSPASM 19 0.0016
334 INFLUENZA 130 0.0016
335 AGE-RELATED MACULAR DEGENERATION 2 0.0016
336 GLUCOSE TOLERANCE IMPAIRED 7 0.0015
337 PRODUCT RESIDUE PRESENT 5 0.0015
338 OESOPHAGEAL DISORDER 5 0.0015
339 HYPOPNOEA 4 0.0015
340 HYPERTHYROIDISM 17 0.0015
341 MUSCULOSKELETAL DISCOMFORT 21 0.0015
342 LUNG INFECTION 24 0.0015
343 HYPOGAMMAGLOBULINAEMIA 6 0.0015
344 SKIN INJURY 4 0.0015
345 WOUND 30 0.0015
346 REGURGITATION 4 0.0015
347 INCREASED UPPER AIRWAY SECRETION 7 0.0015
348 CONCUSSION 9 0.0015
349 NEUTROPENIC SEPSIS 9 0.0015
350 PSYCHIATRIC SYMPTOM 9 0.0015
351 BREATH ODOUR 3 0.0015
352 DRUG DOSE OMISSION BY DEVICE 26 0.0015
353 SPINAL COLUMN STENOSIS 7 0.0015
354 IMMUNE SYSTEM DISORDER 15 0.0015
355 DYSGEUSIA 93 0.0015
356 BLISTER 63 0.0015
357 SINUS TACHYCARDIA 17 0.0015
358 HIATUS HERNIA 16 0.0015
359 PRODUCT PACKAGING ISSUE 10 0.0015
360 BASAL CELL CARCINOMA 18 0.0015
361 EXTRA DOSE ADMINISTERED 32 0.0014
362 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0014
363 HICCUPS 9 0.0014
364 RESPIRATORY RATE INCREASED 10 0.0014
365 COMPRESSION FRACTURE 5 0.0014
366 ATYPICAL PNEUMONIA 3 0.0014
367 HAEMOPTYSIS 32 0.0014
368 AORTIC ANEURYSM 9 0.0014
369 ADRENAL DISORDER 2 0.0014
370 NASAL DISORDER 3 0.0014
371 DECREASED ACTIVITY 11 0.0014
372 PLEURISY 7 0.0014
373 TUMOUR HAEMORRHAGE 3 0.0014
374 AORTIC VALVE STENOSIS 2 0.0014
375 RHINORRHOEA 66 0.0014
376 CHILLS 128 0.0013
377 OEDEMA 57 0.0013
378 DYSPNOEA AT REST 3 0.0013
379 PRODUCT DOSE OMISSION ISSUE 177 0.0013
380 ATRIAL FIBRILLATION 105 0.0013
381 UNDERDOSE 77 0.0013
382 PRODUCT USE ISSUE 186 0.0013
383 HEAD INJURY 33 0.0013
384 ORAL DISCOMFORT 15 0.0013
385 ACUTE RESPIRATORY FAILURE 19 0.0013
386 CAROTID ARTERY STENOSIS 4 0.0013
387 BODY TEMPERATURE DECREASED 11 0.0013
388 PRODUCT USE IN UNAPPROVED INDICATION 203 0.0013
389 TEMPERATURE INTOLERANCE 10 0.0013
390 QUALITY OF LIFE DECREASED 14 0.0013
391 IMPAIRED QUALITY OF LIFE 12 0.0013
392 HYPERTENSION 217 0.0013
393 CLAVICLE FRACTURE 4 0.0013
394 VITAMIN D DECREASED 9 0.0013
395 HEART VALVE INCOMPETENCE 3 0.0013
396 OBESITY 15 0.0013
397 THROAT CLEARING 3 0.0013
398 MUSCULAR WEAKNESS 113 0.0012
399 BLOOD PRESSURE INCREASED 152 0.0012
400 ENDOCARDITIS 5 0.0012
401 HAEMOGLOBIN DECREASED 103 0.0012
402 RENAL TUBULAR DISORDER 3 0.0012
403 HYPERVENTILATION 6 0.0012
404 HEAD DISCOMFORT 16 0.0012
405 SPINAL STENOSIS 3 0.0012
406 ACCIDENT 11 0.0012
407 ATAXIA 12 0.0012
408 SNEEZING 20 0.0012
409 PERIPHERAL SWELLING 138 0.0012
410 DRUG SCREEN FALSE POSITIVE 3 0.0012
411 DEMENTIA 24 0.0012
412 VITAMIN D DEFICIENCY 9 0.0012
413 NERVOUSNESS 53 0.0012
414 SPONDYLITIS 3 0.0012
415 URINARY TRACT DISORDER 4 0.0011
416 FOOT DEFORMITY 10 0.0011
417 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0011
418 BLOOD URIC ACID INCREASED 5 0.0011
419 CONDITION AGGRAVATED 247 0.0011
420 EAR DISCOMFORT 9 0.0011
421 MUSCULOSKELETAL CHEST PAIN 14 0.0011
422 THERAPEUTIC RESPONSE CHANGED 3 0.0011
423 WHEELCHAIR USER 4 0.0011
424 EXERCISE TOLERANCE DECREASED 5 0.0011
425 THYROID MASS 3 0.0011
426 ABNORMAL LOSS OF WEIGHT 6 0.0011
427 GAIT DISTURBANCE 173 0.0011
428 PRODUCT PACKAGING QUANTITY ISSUE 7 0.0011
429 THROAT IRRITATION 38 0.0011
430 WEIGHT DECREASED 244 0.0011
431 PULMONARY HYPERTENSION 19 0.0011
432 DRY MOUTH 69 0.0011
433 INFLUENZA LIKE ILLNESS 76 0.0011
434 ANXIETY DISORDER 3 0.0011
435 ASPIRATION 9 0.0011
436 MELAENA 20 0.0011
437 THYROID DISORDER 13 0.0011
438 BURNING SENSATION 62 0.0011
439 HEPATIC ENZYME INCREASED 55 0.0011
440 SUSPECTED COVID-19 3 0.0011
441 AUTOIMMUNE THYROIDITIS 3 0.0011
442 BACK DISORDER 14 0.0011
443 SYSTEMIC LUPUS ERYTHEMATOSUS 25 0.0011
444 UPPER RESPIRATORY TRACT INFECTION 38 0.0011
445 FLANK PAIN 8 0.0011
446 WEIGHT FLUCTUATION 8 0.0010
447 CARDIAC FAILURE CONGESTIVE 77 0.0010
448 SEASONAL ALLERGY 10 0.0010
449 NON-CARDIAC CHEST PAIN 3 0.0010
450 BALANCE DISORDER 74 0.0010
451 OFF LABEL USE 577 0.0010
452 DIABETES MELLITUS 66 0.0010
453 SYNCOPE 84 0.0010
454 FOREIGN BODY 4 0.0010
455 OEDEMA PERIPHERAL 107 0.0010
456 NASAL DRYNESS 5 0.0010
457 CHOLECYSTECTOMY 9 0.0010
458 MUSCLE DISORDER 7 0.0010
459 EXTRASYSTOLES 6 0.0010
460 CORONARY ARTERY OCCLUSION 12 0.0010
461 HIP FRACTURE 25 0.0010
462 TASTE DISORDER 11 0.0010
463 WEIGHT INCREASED 172 0.0010
464 NODULE 10 0.0010
465 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 3 0.0010
466 INABILITY TO AFFORD MEDICATION 5 0.0010
467 BLADDER DISORDER 8 0.0010
468 PNEUMOTHORAX 12 0.0010
469 ORAL MUCOSAL BLISTERING 5 0.0010
470 PULMONARY OEDEMA 35 0.0010
471 INFLAMMATION 36 0.0010
472 MIGRAINE 69 0.0010
473 HEART RATE ABNORMAL 4 0.0010
474 MALAISE 346 0.0010
475 OEDEMA MOUTH 3 0.0010
476 ANKLE FRACTURE 12 0.0009
477 CARDIAC DISORDER 74 0.0009
478 INTENTIONAL PRODUCT USE ISSUE 59 0.0009
479 PROSTATOMEGALY 3 0.0009
480 BLOOD CHOLESTEROL INCREASED 34 0.0009
481 SINUS CONGESTION 10 0.0009
482 EYE INFLAMMATION 6 0.0009
483 NON-SMALL CELL LUNG CANCER 3 0.0009
484 BREAST MASS 5 0.0009
485 NEPHROGENIC ANAEMIA 4 0.0009
486 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0009
487 SLEEP DISORDER 47 0.0009
488 DYSPEPSIA 70 0.0009
489 HAEMORRHAGIC ANAEMIA 4 0.0009
490 CHOKING SENSATION 4 0.0009
491 NASOPHARYNGITIS 127 0.0009
492 BLOOD PRESSURE INADEQUATELY CONTROLLED 5 0.0009
493 DIVERTICULUM 6 0.0009
494 ARTERIAL OCCLUSIVE DISEASE 6 0.0009
495 BACK INJURY 7 0.0009
496 FOOT FRACTURE 14 0.0009
497 ATRIAL FLUTTER 6 0.0009
498 SKIN ABRASION 3 0.0009
499 OCULAR DISCOMFORT 6 0.0009
500 LUNG INFILTRATION 7 0.0009
501 INCORRECT DOSE ADMINISTERED 128 0.0009
502 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0009
503 PNEUMONITIS 17 0.0009
504 ABDOMINAL DISTENSION 70 0.0009
505 END STAGE RENAL DISEASE 14 0.0008
506 SPINAL FRACTURE 13 0.0008
507 IMMOBILE 3 0.0008
508 VIRAL INFECTION 21 0.0008
509 HYPOXIA 23 0.0008
510 FACIAL BONES FRACTURE 3 0.0008
511 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0008
512 BONE CANCER 3 0.0008
513 FALL 224 0.0008
514 BEDRIDDEN 9 0.0008
515 COVID-19 PNEUMONIA 7 0.0008
516 STAPHYLOCOCCAL INFECTION 23 0.0008
517 POOR PERIPHERAL CIRCULATION 3 0.0008
518 CARDIAC VALVE DISEASE 4 0.0008
519 HERPES ZOSTER 38 0.0008
520 ARTHRITIS 51 0.0008
521 GUILLAIN-BARRE SYNDROME 3 0.0008
522 INCORRECT DOSAGE ADMINISTERED 3 0.0008
523 CATHETERISATION CARDIAC 3 0.0008
524 BLINDNESS 25 0.0008
525 ILL-DEFINED DISORDER 27 0.0008
526 ABDOMINAL HERNIA 3 0.0008
527 DYSPHAGIA 58 0.0008
528 SCOLIOSIS 4 0.0008
529 SPINAL DISORDER 6 0.0008
530 THROAT TIGHTNESS 17 0.0008
531 SINUS HEADACHE 4 0.0008
532 CHEST PAIN 118 0.0008
533 MYOCARDIAL INFARCTION 120 0.0008
534 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0008
535 NASAL DISCOMFORT 5 0.0008
536 HAEMORRHAGIC STROKE 5 0.0008
537 JOINT RANGE OF MOTION DECREASED 7 0.0008
538 NERVE INJURY 7 0.0008
539 LIP DRY 4 0.0007
540 RESPIRATORY DISTRESS 17 0.0007
541 STENT PLACEMENT 5 0.0007
542 STREPTOCOCCAL INFECTION 3 0.0007
543 GASTROINTESTINAL INFECTION 5 0.0007
544 ATELECTASIS 6 0.0007
545 THERAPY CESSATION 28 0.0007
546 HOSPICE CARE 5 0.0007
547 FIBROMYALGIA 13 0.0007
548 ILLNESS 32 0.0007
549 PARAESTHESIA ORAL 8 0.0007
550 ACUTE MYOCARDIAL INFARCTION 18 0.0007
551 VISION BLURRED 76 0.0007
552 TACHYCARDIA 50 0.0007
553 WOUND INFECTION 5 0.0007
554 PRODUCT USE COMPLAINT 6 0.0007
555 SPEECH DISORDER 30 0.0007
556 TENDERNESS 6 0.0007
557 ECCHYMOSIS 4 0.0007
558 FEELING ABNORMAL 140 0.0007
559 PERICARDITIS 7 0.0007
560 MOUTH ULCERATION 11 0.0007
561 THINKING ABNORMAL 11 0.0007
562 SPINAL COMPRESSION FRACTURE 5 0.0007
563 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0007
564 DRUG DEPENDENCE 102 0.0007
565 MUSCLE SPASMS 99 0.0007
566 OSTEOARTHRITIS 22 0.0007
567 PRESCRIBED OVERDOSE 10 0.0007
568 GALLBLADDER DISORDER 10 0.0007
569 RETCHING 11 0.0007
570 PELVIC FRACTURE 4 0.0006
571 IRRITABILITY 33 0.0006
572 DRY EYE 20 0.0006
573 VISUAL FIELD DEFECT 4 0.0006
574 INTESTINAL HAEMORRHAGE 3 0.0006
575 BACK PAIN 121 0.0006
576 UPPER LIMB FRACTURE 11 0.0006
577 PYREXIA 177 0.0006
578 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 92 0.0006
579 PNEUMONIA BACTERIAL 4 0.0006
580 SALIVARY HYPERSECRETION 5 0.0006
581 HAEMOGLOBIN ABNORMAL 3 0.0006
582 DECREASED APPETITE 112 0.0006
583 GOUT 9 0.0006
584 BRAIN INJURY 5 0.0006
585 DEVICE USE ERROR 15 0.0006
586 ANGIOPATHY 3 0.0006
587 NEPHROPATHY 5 0.0006
588 URINARY TRACT INFECTION 82 0.0006
589 LOCALISED INFECTION 12 0.0006
590 PROSTATIC DISORDER 3 0.0006
591 TREMOR 85 0.0006
592 FEELING JITTERY 10 0.0006
593 STRESS 34 0.0006
594 EYE INFECTION 5 0.0006
595 CARDIAC FAILURE ACUTE 3 0.0006
596 LACRIMATION INCREASED 13 0.0006
597 ORAL PAIN 11 0.0006
598 OSTEONECROSIS OF JAW 13 0.0006
599 HUNGER 5 0.0006
600 MYALGIA 81 0.0006
601 PULMONARY THROMBOSIS 5 0.0006
602 POST-TRAUMATIC STRESS DISORDER 3 0.0006
603 GASTROENTERITIS VIRAL 8 0.0006
604 TENSION 3 0.0006
605 SCRATCH 4 0.0006
606 HYPERLIPIDAEMIA 6 0.0006
607 PLEURAL EFFUSION 29 0.0006
608 APHTHOUS ULCER 3 0.0006
609 CARDIAC FLUTTER 3 0.0006
610 DEPRESSION 112 0.0006
611 INFUSION SITE ERYTHEMA 3 0.0006
612 POLYNEUROPATHY 5 0.0006
613 HEART RATE IRREGULAR 11 0.0006
614 ANXIETY 132 0.0006
615 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0006
616 COLITIS ISCHAEMIC 3 0.0006
617 APPARENT DEATH 2 0.0006
618 TROPONIN INCREASED 3 0.0006
619 MEDICATION ERROR 25 0.0006
620 DIVERTICULITIS 12 0.0005
621 ULCER HAEMORRHAGE 3 0.0005
622 GROIN PAIN 4 0.0005
623 DYSGRAPHIA 3 0.0005
624 HYPERSENSITIVITY 81 0.0005
625 AMNESIA 30 0.0005
626 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0005
627 CARDIOMEGALY 6 0.0005
628 AGEUSIA 11 0.0005
629 CEREBRAL DISORDER 3 0.0005
630 HYPERTENSIVE CRISIS 5 0.0005
631 BOWEL MOVEMENT IRREGULARITY 3 0.0005
632 URINE OUTPUT DECREASED 4 0.0005
633 SWOLLEN TONGUE 14 0.0005
634 LARGE INTESTINE POLYP 3 0.0005
635 SCIATICA 6 0.0005
636 PAIN IN EXTREMITY 130 0.0005
637 INTERNAL HAEMORRHAGE 5 0.0005
638 LACERATION 5 0.0005
639 SPINAL OPERATION 4 0.0005
640 HAND FRACTURE 3 0.0005
641 GASTROINTESTINAL HAEMORRHAGE 39 0.0005
642 DRUG HYPERSENSITIVITY 84 0.0005
643 DRUG DISPENSING ERROR 8 0.0005
644 MOUTH HAEMORRHAGE 3 0.0005
645 JOINT EFFUSION 3 0.0005
646 KIDNEY INFECTION 8 0.0005
647 MOBILITY DECREASED 29 0.0005
648 TOXIC EPIDERMAL NECROLYSIS 6 0.0005
649 ADRENAL INSUFFICIENCY 4 0.0005
650 HYPOPHAGIA 10 0.0005
651 POST PROCEDURAL HAEMORRHAGE 5 0.0005
652 OVARIAN CANCER 4 0.0005
653 TOOTH LOSS 9 0.0005
654 BLOOD PRESSURE DECREASED 27 0.0005
655 ANAL ABSCESS 2 0.0005
656 BLOOD LACTIC ACID INCREASED 2 0.0005
657 GENERAL PHYSICAL HEALTH DETERIORATION 42 0.0005
658 GASTRIC ULCER 8 0.0005
659 PRODUCT CONTAINER ISSUE 3 0.0005
660 HEARING IMPAIRED 3 0.0005
661 PAROSMIA 3 0.0005
662 ELECTROCARDIOGRAM QT PROLONGED 14 0.0005
663 DEVICE DIFFICULT TO USE 15 0.0005
664 FUNGAL INFECTION 13 0.0005
665 PHARYNGITIS 5 0.0005
666 DISCOMFORT 21 0.0005
667 THERAPY INTERRUPTED 14 0.0005
668 FLUID RETENTION 20 0.0005
669 PRODUCT ADMINISTRATION ERROR 6 0.0005
670 HAEMATOCHEZIA 20 0.0005
671 ASPHYXIA 3 0.0005
672 RENAL PAIN 4 0.0005
673 DRUG INTOLERANCE 34 0.0005
674 OSTEOPENIA 6 0.0005
675 ROTATOR CUFF SYNDROME 5 0.0005
676 NEOPLASM MALIGNANT 24 0.0005
677 PALPITATIONS 44 0.0005
678 INTENTIONAL DOSE OMISSION 5 0.0005
679 ERUCTATION 6 0.0005
680 CONTUSION 35 0.0005
681 MENTAL IMPAIRMENT 9 0.0005
682 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
683 ABDOMINAL PAIN 84 0.0005
684 SENSORY LOSS 3 0.0005
685 CEREBROVASCULAR ACCIDENT 65 0.0005
686 LIMB DISCOMFORT 11 0.0004
687 HEPATITIS C 5 0.0004
688 ADVERSE EVENT 33 0.0004
689 ADVERSE DRUG REACTION 28 0.0004
690 DECUBITUS ULCER 3 0.0004
691 FATIGUE 268 0.0004
692 DIZZINESS 176 0.0004
693 ASTHENIA 130 0.0004
694 PARAESTHESIA 57 0.0004
695 BACTERIAL INFECTION 6 0.0004
696 PULMONARY EMBOLISM 35 0.0004
697 MUSCLE ATROPHY 4 0.0004
698 LOWER LIMB FRACTURE 6 0.0004
699 COAGULOPATHY 6 0.0004
700 FLATULENCE 19 0.0004
701 HEPATIC CIRRHOSIS 6 0.0004
702 ANAEMIA 66 0.0004
703 BRAIN NEOPLASM 3 0.0004
704 PRURITUS 112 0.0004
705 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
706 DEPRESSED MOOD 17 0.0004
707 FEAR 10 0.0004
708 LIP SWELLING 11 0.0004
709 SKIN CANCER 7 0.0004
710 CYSTITIS 11 0.0004
711 EYE DISCHARGE 3 0.0004
712 HYPERHIDROSIS 44 0.0004
713 FLUID OVERLOAD 6 0.0004
714 NERVE COMPRESSION 3 0.0004
715 BREAST CANCER FEMALE 10 0.0004
716 CONFUSIONAL STATE 54 0.0004
717 CHRONIC KIDNEY DISEASE 28 0.0004
718 ARTHRALGIA 127 0.0004
719 HYPERSOMNIA 9 0.0004
720 LIGAMENT SPRAIN 3 0.0004
721 LYMPHOMA 5 0.0004
722 THERAPEUTIC RESPONSE DECREASED 18 0.0004
723 BONE DENSITY DECREASED 11 0.0004
724 SARS-COV-2 TEST POSITIVE 4 0.0004
725 UNEVALUABLE EVENT 25 0.0004
726 RENAL IMPAIRMENT 25 0.0004
727 TENDON RUPTURE 4 0.0004
728 HEADACHE 192 0.0004
729 INCORRECT PRODUCT STORAGE 5 0.0004
730 FEEDING DISORDER 5 0.0004
731 EYE PAIN 15 0.0004
732 SUPRAVENTRICULAR TACHYCARDIA 3 0.0004
733 GAIT INABILITY 8 0.0004
734 ARTERIOSCLEROSIS 3 0.0004
735 TOOTH DISORDER 7 0.0004
736 INTRAOCULAR PRESSURE INCREASED 4 0.0004
737 MOTOR DYSFUNCTION 3 0.0004
738 BONE DISORDER 6 0.0004
739 INFECTION 40 0.0004
740 EYE PRURITUS 8 0.0004
741 COLITIS 10 0.0004
742 HYPOTENSION 59 0.0004
743 GLOMERULAR FILTRATION RATE DECREASED 3 0.0004
744 SEIZURE 30 0.0004
745 NEUTROPHIL COUNT INCREASED 3 0.0004
746 EAR INFECTION 7 0.0004
747 OCULAR HYPERAEMIA 12 0.0004
748 PNEUMONIA ASPIRATION 7 0.0004
749 BLINDNESS UNILATERAL 4 0.0004
750 ABDOMINAL DISCOMFORT 46 0.0004
751 HEPATOMEGALY 3 0.0004
752 SCAR 5 0.0004
753 BLOOD PRESSURE FLUCTUATION 7 0.0003
754 VOMITING 128 0.0003
755 MASS 4 0.0003
756 RENAL DISORDER 13 0.0003
757 DIPLOPIA 7 0.0003
758 DEVICE OCCLUSION 3 0.0003
759 EATING DISORDER 6 0.0003
760 ARTHROPOD BITE 2 0.0003
761 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
762 PARALYSIS 4 0.0003
763 PRODUCT PHYSICAL ISSUE 5 0.0003
764 SCAB 3 0.0003
765 INSOMNIA 74 0.0003
766 BRADYCARDIA 15 0.0003
767 NEUTROPHIL COUNT DECREASED 10 0.0003
768 RENAL FAILURE 39 0.0003
769 DRUG EFFECT DECREASED 18 0.0003
770 LOSS OF CONSCIOUSNESS 35 0.0003
771 DRUG INEFFECTIVE 344 0.0003
772 DYSSTASIA 8 0.0003
773 BLOOD SODIUM DECREASED 5 0.0003
774 MOOD SWINGS 9 0.0003
775 HAEMORRHAGE 27 0.0003
776 SPINAL PAIN 3 0.0003
777 HOSPITALISATION 35 0.0003
778 RASH 108 0.0003
779 HYPONATRAEMIA 15 0.0003
780 DIARRHOEA 161 0.0003
781 COGNITIVE DISORDER 12 0.0003
782 OSTEOMYELITIS 5 0.0003
783 BLOOD GLUCOSE FLUCTUATION 3 0.0003
784 GASTRIC DISORDER 11 0.0003
785 PRODUCT PRESCRIBING ERROR 5 0.0003
786 MITRAL VALVE INCOMPETENCE 3 0.0003
787 BIPOLAR DISORDER 3 0.0003
788 VERTIGO 16 0.0003
789 RESPIRATORY FAILURE 19 0.0003
790 ATRIOVENTRICULAR BLOCK 2 0.0003
791 HAEMATOMA 7 0.0003
792 POST PROCEDURAL COMPLICATION 5 0.0003
793 SKIN DISORDER 8 0.0003
794 NECK PAIN 14 0.0003
795 DRUG PRESCRIBING ERROR 6 0.0003
796 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0003
797 PAIN 157 0.0003
798 HYPOKALAEMIA 11 0.0003
799 EXPIRED PRODUCT ADMINISTERED 8 0.0003
800 IMMUNODEFICIENCY 3 0.0003
801 INJECTION SITE PAIN 66 0.0003
802 APNOEA 2 0.0003
803 TUBERCULOSIS 3 0.0003
804 METASTASES TO LIVER 4 0.0003
805 LETHARGY 14 0.0003
806 ARTHROPATHY 13 0.0003
807 URINARY INCONTINENCE 7 0.0003
808 PRODUCT AVAILABILITY ISSUE 3 0.0003
809 HYPOAESTHESIA 35 0.0003
810 ACUTE KIDNEY INJURY 33 0.0003
811 BLOOD POTASSIUM DECREASED 7 0.0003
812 RENAL INJURY 8 0.0003
813 ANGIOEDEMA 10 0.0003
814 MENTAL DISORDER 10 0.0003
815 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0003
816 LYMPHADENOPATHY 8 0.0003
817 FAECES DISCOLOURED 5 0.0003
818 PERICARDIAL EFFUSION 5 0.0003
819 EPISTAXIS 17 0.0003
820 PSYCHOMOTOR HYPERACTIVITY 4 0.0003
821 COLD SWEAT 4 0.0003
822 HEPATIC STEATOSIS 4 0.0003
823 ANAPHYLACTIC REACTION 11 0.0003
824 GASTROINTESTINAL DISORDER 16 0.0003
825 PERIPHERAL COLDNESS 3 0.0003
826 SKIN DISCOLOURATION 10 0.0003
827 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0003
828 NEURALGIA 5 0.0003
829 ABDOMINAL PAIN UPPER 43 0.0003
830 CHROMATURIA 5 0.0003
831 PHARYNGEAL OEDEMA 4 0.0003
832 IRRITABLE BOWEL SYNDROME 4 0.0003
833 FEMUR FRACTURE 7 0.0003
834 JOINT SWELLING 24 0.0003
835 LACTIC ACIDOSIS 6 0.0003
836 MYELODYSPLASTIC SYNDROME 3 0.0003
837 METASTASES TO BONE 3 0.0003
838 CONSTIPATION 41 0.0003
839 RHEUMATOID ARTHRITIS 22 0.0003
840 HAEMORRHOIDS 4 0.0002
841 COLON CANCER 3 0.0002
842 CEREBRAL INFARCTION 5 0.0002
843 DEAFNESS 5 0.0002
844 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
845 HEART RATE DECREASED 7 0.0002
846 ANGINA PECTORIS 6 0.0002
847 ANGER 7 0.0002
848 EJECTION FRACTION DECREASED 3 0.0002
849 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 24 0.0002
850 ROAD TRAFFIC ACCIDENT 8 0.0002
851 PSORIASIS 25 0.0002
852 ANKYLOSING SPONDYLITIS 2 0.0002
853 STOMATITIS 11 0.0002
854 ULCER 3 0.0002
855 DRUG INTERACTION 30 0.0002
856 CARDIAC ARREST 16 0.0002
857 GASTRITIS 5 0.0002
858 PRURITUS GENERALISED 5 0.0002
859 DEVICE BREAKAGE 5 0.0002
860 TENDONITIS 3 0.0002
861 LOCAL SWELLING 4 0.0002
862 BONE LOSS 3 0.0002
863 INCREASED APPETITE 3 0.0002
864 ARRHYTHMIA 9 0.0002
865 PRODUCT DISPENSING ERROR 3 0.0002
866 DRUG EFFECT INCOMPLETE 8 0.0002
867 INTESTINAL OBSTRUCTION 6 0.0002
868 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
869 NAUSEA 134 0.0002
870 PULMONARY FIBROSIS 3 0.0002
871 DEATH 143 0.0002
872 THROMBOSIS 14 0.0002
873 THIRST 3 0.0002
874 PAIN IN JAW 5 0.0002
875 PRESYNCOPE 4 0.0002
876 DISORIENTATION 7 0.0002
877 DRUG RESISTANCE 4 0.0002
878 ANHEDONIA 5 0.0002
879 NIGHT SWEATS 5 0.0002
880 URTICARIA 26 0.0002
881 CEREBRAL HAEMORRHAGE 6 0.0002
882 ABASIA 5 0.0002
883 DEHYDRATION 22 0.0002
884 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
885 FULL BLOOD COUNT DECREASED 3 0.0002
886 DRUG ADMINISTRATION ERROR 6 0.0002
887 FRACTURE 3 0.0002
888 AGITATION 12 0.0002
889 SWELLING 14 0.0002
890 PLATELET COUNT DECREASED 16 0.0002
891 SKIN ULCER 4 0.0002
892 PRODUCT SUBSTITUTION ISSUE 9 0.0002
893 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
894 SOMNOLENCE 30 0.0002
895 POOR QUALITY SLEEP 3 0.0002
896 ACCIDENTAL OVERDOSE 5 0.0002
897 MOOD ALTERED 4 0.0002
898 GLOSSODYNIA 3 0.0002
899 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
900 FEELING HOT 9 0.0002
901 PALLOR 4 0.0002
902 BLOOD GLUCOSE DECREASED 7 0.0002
903 NEUROPATHY PERIPHERAL 12 0.0002
904 RECTAL HAEMORRHAGE 6 0.0002
905 MUSCULOSKELETAL PAIN 8 0.0002
906 INTERVERTEBRAL DISC PROTRUSION 3 0.0002
907 INTERSTITIAL LUNG DISEASE 6 0.0002
908 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0002
909 APHASIA 4 0.0002
910 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0002
911 EYE IRRITATION 6 0.0002
912 PANCREATIC CARCINOMA 4 0.0002
913 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
914 RASH GENERALISED 4 0.0002
915 PRODUCT ADHESION ISSUE 4 0.0002
916 BONE PAIN 7 0.0001
917 NERVOUS SYSTEM DISORDER 4 0.0001
918 SUICIDAL IDEATION 11 0.0001
919 RASH PRURITIC 6 0.0001
920 C-REACTIVE PROTEIN INCREASED 4 0.0001
921 HYPERKALAEMIA 4 0.0001
922 ABDOMINAL PAIN LOWER 3 0.0001
923 MUSCULOSKELETAL STIFFNESS 10 0.0001
924 ABNORMAL BEHAVIOUR 5 0.0001
925 AGGRESSION 6 0.0001
926 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
927 DEVICE LEAKAGE 3 0.0001
928 COVID-19 16 0.0001
929 BLOOD GLUCOSE INCREASED 22 0.0001
930 EYE SWELLING 4 0.0001
931 PRODUCT STORAGE ERROR 6 0.0001
932 FLUSHING 12 0.0001
933 COLITIS ULCERATIVE 4 0.0001
934 SWELLING FACE 7 0.0001
935 RED BLOOD CELL COUNT DECREASED 3 0.0001
936 CARDIOVASCULAR DISORDER 3 0.0001
937 JAUNDICE 3 0.0001
938 TREATMENT NONCOMPLIANCE 5 0.0001
939 CRYING 4 0.0001
940 OVERDOSE 22 0.0001
941 BLADDER CANCER 7 0.0001
942 HOT FLUSH 7 0.0001
943 SEPSIS 11 0.0001
944 RESPIRATORY ARREST 3 0.0001
945 DYSKINESIA 4 0.0001
946 IMPAIRED HEALING 3 0.0001
947 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
948 PANCREATITIS 5 0.0001
949 ERYTHEMA 19 0.0001
950 TARDIVE DYSKINESIA 3 0.0001
951 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
952 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
953 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
954 HALLUCINATION 6 0.0001
955 PROSTATE CANCER 8 0.0001
956 DEEP VEIN THROMBOSIS 6 0.0001
957 BREAST CANCER 9 0.0001
958 ANAPHYLACTIC SHOCK 2 0.0001
959 NIGHTMARE 3 0.0001
960 SKIN BURNING SENSATION 6 0.0001
961 FEBRILE NEUTROPENIA 5 0.0001
962 HYPERGLYCAEMIA 3 0.0001
963 EMOTIONAL DISTRESS 11 0.0001
964 SURGERY 4 0.0001
965 WITHDRAWAL SYNDROME 3 0.0001
966 BLOOD CREATININE INCREASED 5 0.0001
967 DISEASE PROGRESSION 8 0.0001
968 RASH ERYTHEMATOUS 3 0.0001
969 SEPTIC SHOCK 3 0.0001
970 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
971 INFUSION RELATED REACTION 4 0.0001
972 DRY SKIN 8 0.0001
973 ASCITES 2 0.0001
974 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
975 TINNITUS 3 0.0001
976 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
977 COMA 3 0.0001
978 INJECTION SITE PRURITUS 4 0.0001
979 ALOPECIA 12 0.0001
980 TREATMENT FAILURE 4 0.0001
981 RENAL CANCER 3 0.0001
982 INJECTION SITE SWELLING 3 0.0001
983 INJECTION SITE HAEMORRHAGE 3 0.0001
984 SKIN EXFOLIATION 3 0.0000
985 INJURY 3 0.0000
986 DRUG WITHDRAWAL SYNDROME 4 0.0000
987 ACNE 3 0.0000
988 THROMBOCYTOPENIA 4 0.0000
989 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
990 NO ADVERSE EVENT 4 0.0000